Cargando…

ImmReg: the regulon atlas of immune-related pathways across cancer types

Immune system gene regulation perturbation has been found to be a major cause of the development of various types of cancer. Numbers of mechanisms contribute to gene expression regulation, thus, systematically identification of potential regulons of immune-related pathways is critical to cancer immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tiantongfei, Zhou, Weiwei, Chang, Zhenghong, Zou, Haozhe, Bai, Jing, Sun, Qisen, Pan, Tao, Xu, Juan, Li, Yongsheng, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643631/
https://www.ncbi.nlm.nih.gov/pubmed/34755873
http://dx.doi.org/10.1093/nar/gkab1041
_version_ 1784609897533407232
author Jiang, Tiantongfei
Zhou, Weiwei
Chang, Zhenghong
Zou, Haozhe
Bai, Jing
Sun, Qisen
Pan, Tao
Xu, Juan
Li, Yongsheng
Li, Xia
author_facet Jiang, Tiantongfei
Zhou, Weiwei
Chang, Zhenghong
Zou, Haozhe
Bai, Jing
Sun, Qisen
Pan, Tao
Xu, Juan
Li, Yongsheng
Li, Xia
author_sort Jiang, Tiantongfei
collection PubMed
description Immune system gene regulation perturbation has been found to be a major cause of the development of various types of cancer. Numbers of mechanisms contribute to gene expression regulation, thus, systematically identification of potential regulons of immune-related pathways is critical to cancer immunotherapy. Here, we comprehensively chart the landscape of transcription factors, microRNAs, RNA binding proteins and long noncoding RNAs regulation in 17 immune-related pathways across 33 cancers. The potential immunology regulons are likely to exhibit higher expressions in immune cells, show expression perturbations in cancer, and are significantly correlated with immune cell infiltrations. We also identify a panel of clinically relevant immunology regulons across cancers. Moreover, the regulon atlas of immune-related pathways helps prioritizing cancer-related genes (i.e. ETV7, miR-146a-5p, ZFP36 and HCP5). We further identified two molecular subtypes of glioma (cold and hot tumour phenotypes), which were characterized by differences in immune cell infiltrations, expression of checkpoints, and prognosis. Finally, we developed a user-friendly resource, ImmReg (http://bio-bigdata.hrbmu.edu.cn/ImmReg/), with multiple modules to visualize, browse, and download immunology regulation. Our study provides a comprehensive landscape of immunology regulons, which will shed light on future development of RNA-based cancer immunotherapies.
format Online
Article
Text
id pubmed-8643631
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86436312021-12-06 ImmReg: the regulon atlas of immune-related pathways across cancer types Jiang, Tiantongfei Zhou, Weiwei Chang, Zhenghong Zou, Haozhe Bai, Jing Sun, Qisen Pan, Tao Xu, Juan Li, Yongsheng Li, Xia Nucleic Acids Res Data Resources and Analyses Immune system gene regulation perturbation has been found to be a major cause of the development of various types of cancer. Numbers of mechanisms contribute to gene expression regulation, thus, systematically identification of potential regulons of immune-related pathways is critical to cancer immunotherapy. Here, we comprehensively chart the landscape of transcription factors, microRNAs, RNA binding proteins and long noncoding RNAs regulation in 17 immune-related pathways across 33 cancers. The potential immunology regulons are likely to exhibit higher expressions in immune cells, show expression perturbations in cancer, and are significantly correlated with immune cell infiltrations. We also identify a panel of clinically relevant immunology regulons across cancers. Moreover, the regulon atlas of immune-related pathways helps prioritizing cancer-related genes (i.e. ETV7, miR-146a-5p, ZFP36 and HCP5). We further identified two molecular subtypes of glioma (cold and hot tumour phenotypes), which were characterized by differences in immune cell infiltrations, expression of checkpoints, and prognosis. Finally, we developed a user-friendly resource, ImmReg (http://bio-bigdata.hrbmu.edu.cn/ImmReg/), with multiple modules to visualize, browse, and download immunology regulation. Our study provides a comprehensive landscape of immunology regulons, which will shed light on future development of RNA-based cancer immunotherapies. Oxford University Press 2021-11-10 /pmc/articles/PMC8643631/ /pubmed/34755873 http://dx.doi.org/10.1093/nar/gkab1041 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Data Resources and Analyses
Jiang, Tiantongfei
Zhou, Weiwei
Chang, Zhenghong
Zou, Haozhe
Bai, Jing
Sun, Qisen
Pan, Tao
Xu, Juan
Li, Yongsheng
Li, Xia
ImmReg: the regulon atlas of immune-related pathways across cancer types
title ImmReg: the regulon atlas of immune-related pathways across cancer types
title_full ImmReg: the regulon atlas of immune-related pathways across cancer types
title_fullStr ImmReg: the regulon atlas of immune-related pathways across cancer types
title_full_unstemmed ImmReg: the regulon atlas of immune-related pathways across cancer types
title_short ImmReg: the regulon atlas of immune-related pathways across cancer types
title_sort immreg: the regulon atlas of immune-related pathways across cancer types
topic Data Resources and Analyses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643631/
https://www.ncbi.nlm.nih.gov/pubmed/34755873
http://dx.doi.org/10.1093/nar/gkab1041
work_keys_str_mv AT jiangtiantongfei immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT zhouweiwei immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT changzhenghong immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT zouhaozhe immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT baijing immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT sunqisen immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT pantao immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT xujuan immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT liyongsheng immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes
AT lixia immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes